A study by Ausnutria Hyproca and research institute Triskelion (formerly known as TNO), shows that the kinetics of protein digestion of Kabrita goat milk infant formula is more comparable to that of human milk.
In the study, a dynamic in vitro digestion model (Tiny-TIM) was used to simulate the conditions in the stomach and small intestine of infants (1-6 months of age). Three samples (human milk, a cow milk infant formula and Kabrita goat milk infant formula) were tested. Results show that kinetics of protein digestion of Kabrita infant formula is similar to that of human milk, while protein digestion of the cow milk infant formula is delayed in comparison to human milk and Kabrita infant formula. The protein quality is not different among the three tested samples. The potential benefits of these results need further investigation.
Breast-feeding is the best choice for babies. When breast-feeding is not sufficient or not possible, it is important to have high quality infant formulas available. Traditionally, infant formula is based on cow’s milk. Nevertheless, there is an increasing consumer demand for goat milk-based infant formula. Alfred Haandrikman, R&D Director at Ausnutria Hyproca B.V.:“The knowledge about the functionalities of goat milk is not yet completed. As a company we strive to expand the knowledge on how the natural composition of goat milk can contribute to the health and wellbeing of our smallest consumers. For that purpose we collaborate with universities and research institutes all over the world.”
About Ausnutria Hyproca
Ausnutria Hyproca is located in the Netherlands, where the company owns three infant formula factories. The company collects around 50 million kilos of goat milk per year, which is used to produce Kabrita goat milk infant formula. The goat milk is supplied by a select group of around 50 family-owned Dutch goat farmers, who have fully committed themselves to the high quality standards of the company. Kabrita is the main global player in the field of goat milk infant formula and toddler formula, currently sold in i.a. the EU, the Middle East, China and Russia. The company is working on the FDA approval for Kabrita infant formula (0-12 months) in the USA.
